Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Cocoa Flavanols (flavanol-rich cocoa extract)
Flavanol-rich extract from cocoa beans, standardized for epicatechin. The largest trial (COSMOS, 21,442 adults) MISSED its primary cardiovascular endpoint but cut CVD death by 27% as a secondary outcome. Meta-analyses show a small (~2 mmHg) blood-pressure drop and improved endothelial function; cognitive benefit in the same trial was null.
What the evidence says
Cocoa Flavanols doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from high-quality meta-analyses and randomised trials published 2003–2026 with a typical study size of 21,442 participants.
Based on 88 studies · 5 meta-analyses · 72 RCTs · 21,442 total participants
Study base
88 studies indexedBy outcome
Every outcome below: Too few graded studies.
Meta-analyses consistently show a small (~2 mmHg) blood-pressure drop and improved endothelial function, but the large COSMOS trial missed its primary cardiovascular endpoint and cognitive benefit was null — supporting a moderate score.
72 randomised trials
90% were about Cocoa Flavanols in an audit of 50 of them
Every randomised or controlled trial of Cocoa Flavanols indexed in PubMed, not a hand-picked subset. Meta-analyses and systematic reviews are deliberately excluded from this count: most of them cover many compounds at once, so counting them would inflate it.
PubMed · as of Sep 2026
8 trials ongoing or recruiting · 51 completed on ClinicalTrials.gov
5 of the completed trials have posted results
Registered trials show research momentum for Cocoa Flavanols, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Nov 2026
Under EU law (Reg. 1924/2006), EFSA reviews whether a specific health claim for Cocoa Flavanols meets the evidence standard. These are independent regulatory decisions on claims — not studies, and never counted toward the evidence score above.
Not authorised by EFSA
“Cocoa flavanols Maintenance and promotion of a normal blood pressure”
“Not authorised” means the specific claim wording did not meet the EU’s evidence standard — often a matter of dossier or phrasing, not proof of no effect. EFSA judges marketing claims and is kept separate from our study-based evidence score.
Source: EU Register of nutrition and health claims (European Commission / EFSA) · register snapshot Feb 2013
Cocoa flavanols are polyphenols (chiefly epicatechin and procyanidins) concentrated from cocoa beans into standardized extracts. The headline trial is COSMOS (2022) — a randomized, double-blind, placebo-controlled trial in 21,442 older US adults taking 500mg cocoa flavanols daily for a median 3.6 years.
Reported honestly: the PRIMARY endpoint (total cardiovascular events) was NOT statistically significant (HR 0.90, 95% CI 0.78-1.02, P=0.11).
However, a secondary endpoint — cardiovascular death — was reduced by 27% (HR 0.73, 95% CI 0.54-0.98), and per-protocol analysis (accounting for nonadherence) did show a lower risk of total CV events.
Supporting mechanism trials and meta-analyses are more consistent: a Cochrane review found flavanol-rich cocoa lowers blood pressure by about 2 mmHg short-term, and a dose-response meta-analysis found improved flow-mediated dilation (endothelial function), with a modeled dose-response estimate that does not establish an individual optimal dose.
Cognition is a genuine mixed bag: an early Brickman RCT linked flavanols to better dentate-gyrus-dependent memory, but the large COSMOS-Mind sub-trial found NO cognitive benefit from cocoa extract over 3 years.
Net: a plausible vascular benefit with one positive secondary mortality signal, but the primary outcome was negative and cognitive claims are not supported by the best trial.
Epicatechin enhances endothelial nitric-oxide production, promoting vasodilation and improved flow-mediated dilation.
Improved vascular tone produces a small (~2 mmHg) short-term reduction in blood pressure, larger in (pre)hypertensive people.
Flavanols increase hippocampal/cerebral blood volume in imaging studies — the proposed basis for any cognitive effect (which the largest trial did not confirm).
How Cocoa Flavanols works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Take earlier in the day; choose lower-caffeine extracts.
Dietary cocoa is fine; standardized high-dose extracts are not specifically studied — use food sources or consult a clinician.
Additive small blood-pressure-lowering effect — generally benign but worth noting if BP is already well controlled.
Cocoa contains theobromine and modest caffeine; may affect sensitive individuals if taken late in the day.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: Persistent or troublesome digestive symptoms should be reviewed with a pharmacist or clinician.
Cocoa Flavanols has an evidence score of 5/10 — moderate evidence based on 88 indexed studies, including 2 meta-analyses. Flavanol-rich extract from cocoa beans, standardized for epicatechin. The largest trial (COSMOS, 21,442 adults) MISSED its primary cardiovascular endpoint but cut CVD death by 27% as a secondary outcome. Meta-analyses show a small (~2 mmHg) blood-pressure drop and improved endothelial function; cognitive benefit in the same trial was null. Representative study: PMID 28439881.
Timing is flexible for Cocoa Flavanols — consistent daily use matters more than the time of day. No strong timing dependence; can be split.
Cocoa Flavanols is generally well-tolerated and considered safe for most healthy adults at recommended doses. Reported side effects include gastrointestinal complaints / nausea. How often they occur is not established for all of them. Use caution if any of these apply to you: Caffeine sensitivity (cocoa contains some caffeine/theobromine); Caution with the added sugar/fat if consumed as chocolate.
Sage
Too few graded studiesA Mediterranean herb with rosmarinic acid and salvianolic compounds that support cognitive function, menopausal symptom relief, and metabolic health through antioxidant and cholinergic mechanisms.
Aged Garlic Extract
HelpedOdorless garlic extract with evidence for blood pressure and cardiovascular markers, and one trial reporting milder colds and flu.
Beetroot
HelpedDietary nitrates convert to nitric oxide, enhancing oxygen delivery to muscles — a top-5 evidence-based ergogenic aid.
Saffron
HelpedBeat placebo for depression in meta-analyses, and small trials found no significant difference versus SSRIs, which does not show equal effect. Also studied for anxiety and PMS symptoms.
Explore: Best supplements for Vitality & LongevityBest supplements for Focus, Memory & Mood
Edited by Dr. Baher Al Hakim · Last updated November 2026 · evidence from 88 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Cocoa Flavanols
Flavanol-rich extract from cocoa beans, standardized for epicatechin. The larges
Nitric-oxide / endothelial signaling
Epicatechin enhances endothelial nitric-oxide production, promoting vasodilation and impro
Blood-pressure lowering
Improved vascular tone produces a small (~2 mmHg) short-term reduction in blood pressure,
Heart Health
Cocoa Flavanols → Heart Health
Neuronal Survival
Cocoa Flavanols → Neuronal Survival
Focus
Cocoa Flavanols → Focus